Fresenius SE & Co. (OTCMKTS:FSNUY) Short Interest Update

Fresenius SE & Co. (OTCMKTS:FSNUY) was the recipient of a large decline in short interest in the month of December. As of December 31st, there was short interest totaling 11,203 shares, a decline of 88.7% from the December 15th total of 98,734 shares. Approximately 0.0% of the company’s shares are sold short. Based on an average daily trading volume, of 48,099 shares, the days-to-cover ratio is presently 0.2 days. Based on an average daily trading volume, of 48,099 shares, the days-to-cover ratio is presently 0.2 days. Approximately 0.0% of the company’s shares are sold short.

Fresenius SE & Co. Price Performance

Shares of OTCMKTS FSNUY opened at $14.82 on Tuesday. The company has a current ratio of 1.26, a quick ratio of 0.99 and a debt-to-equity ratio of 0.49. Fresenius SE & Co. has a 12-month low of $8.80 and a 12-month high of $33.93. The business’s fifty day simple moving average is $14.22 and its 200-day simple moving average is $13.87.

Fresenius SE & Co. (OTCMKTS:FSNUY) last issued its quarterly earnings results on Wednesday, November 5th. The company reported $0.23 earnings per share for the quarter, topping the consensus estimate of $0.21 by $0.02. Fresenius SE & Co. had a return on equity of 9.72% and a net margin of 5.26%.The company had revenue of $6.29 billion for the quarter, compared to the consensus estimate of $6.38 billion. As a group, equities research analysts expect that Fresenius SE & Co. will post 0.79 EPS for the current year.

Analysts Set New Price Targets

FSNUY has been the subject of a number of recent analyst reports. Deutsche Bank Aktiengesellschaft reissued a “buy” rating on shares of Fresenius SE & Co. in a research report on Monday, October 27th. Morgan Stanley reiterated an “overweight” rating on shares of Fresenius SE & Co. in a report on Monday, December 15th. Two equities research analysts have rated the stock with a Buy rating, According to MarketBeat.com, the company has a consensus rating of “Buy”.

About Fresenius SE & Co.

Fresenius SE & Co KGaA is a global healthcare group headquartered in Bad Homburg vor der Höhe, Germany. Founded in 1912 by Eduard Fresenius, the company has grown into one of the world’s leading providers of products and services for dialysis, hospitals and outpatient medical care. Trading on major European exchanges and available over the counter in the U.S. as FSNUY, Fresenius SE & Co brings together a portfolio of specialized healthcare businesses under one corporate umbrella.

The company operates through four main business segments.